Pharmaceutical crops in California, benefits and risks. A review

  title={Pharmaceutical crops in California, benefits and risks. A review},
  author={M. Marvier},
  journal={Agronomy for Sustainable Development},
  • M. Marvier
  • Published 2011
  • Business
  • Agronomy for Sustainable Development
Crops are being genetically engineered to produce a wide variety of drugs, vaccines and other pharmaceutical proteins. Although these crops may open the door to less expensive and more readily available drugs, there is concern regarding the potential for contamination of human food and livestock feed, as well as environmental harm. The outlook for the production of pharmaceutical crops in California currently appears mixed. To date, 18 federal permits for field trials involving pharmaceutical… Expand

Figures and Tables from this paper

- Non-Traditional Uses of Maize: Biofuels, Remediation and Pharmaceuticals
Traditionally, plants have been used for a variety of applications in addition to food and feed, including manufacture of industrial products, vaccines and pharmaceuticals. Maize has the potential toExpand
A Meta-Analysis for the Impact of Transgenic Crop Adoption on Corn and Soybean Yield
Although there is a broad dispute over genetically modified foods on safety, the worldwide adoption of transgenic crops is rapidly increasing. The objectives of this study were to identify trends inExpand
Sustainable Weed, Disease and Pest Management in Medicinal and Aromatic Plants
As for all other crops, in MAPs as well, weeds, diseases and pests are important yield-reducing factors, which may severely curtain biomass production and, that is maybe more important, may affectExpand
Identifying disease threats and management practices for bio-energy crops
Current research on bio-energy crops is focused almost exclusively on selection of high performing varieties and development of optimum agronomic practices, but there has been only cursory referenceExpand
Organic Bread Wheat Production and Market in Europe
This chapter is a first attempt to analyse bottlenecks and challenges of European organic bread wheat sector involving technical, political and market issues. From 2000, the organic grain market hasExpand
Alternative cropping systems can have contrasting effects on various soil-borne diseases: Relevance of a systemic analysis in vegetable cropping systems
The results should motivate farmers and advisers to adopt a systemic analysis and take into account the various interactions among inoculum level, soil characteristics, crop rotations, and technical management options for designing sustainable vegetable production systems. Expand
Gene Flow, Invasiveness, and Ecological Impact of Genetically Modified Crops
A better understanding of factors controlling population size, dynamics, and range limits in weedy volunteer GM crop and related host or target weed populations is necessary before the effect of biotic and abiotic stress‐tolerance GM traits can be fully assessed. Expand
Comment favoriser la régulation biologique des insectes de l’échelle de la parcelle à celle du paysage agricole, pour aboutir à des stratégies de protection intégrée sur le colza d’hiver ?
Continuous increases in the use of synthetic fertilisers and pesticides in agro-ecosystems have led to an increase in crop production, but also to a simplification of landscape and a decline inExpand
Combining solar photovoltaic panels and food crops for optimising land use: Towards new agrivoltaic schemes
The need for new sources of renewable energies and the rising price of fossil fuels have induced the hope that agricultural crops may be a source of renewable energy for the future. We question inExpand
Sustainability of Energy Crop Cultivation in Central Europe
Currently biomass contributes to 69 106 tons of oil equivalents (MtOE) or 4% of the total energy consumption in Europe. According to the European Union (EU) Biomass Action Plan biofuels shallExpand


Biopharming and the Food System: Examining the Potential Benefits and Risks
Advances in genetic engineering now make it possible to use crops such as corn and tobacco as drug factories. Plants used as bioreactors (biopharming) may soon represent one of the most importantExpand
Safe and acceptable strategies for producing foreign molecules in plants.
The ability to express foreign genes using transgenic technologies has opened up options for producing large quantities of commercially important industrial or pharmaceutical products in plants, which has prompted detailed consideration of how such crops and the molecules that they produce can be effectively isolated and contained. Expand
Molecular farming for new drugs and vaccines
Attention is now shifting from basic research towards commercial exploitation, and molecular farming is reaching the stage at which it could challenge established production technologies that use bacteria, yeast and cultured mammalian cells. Expand
Risk analysis for plant-made vaccines
The value of new or replacement vaccines produced in plant cells and delivered orally must be considered alongside the probability and severity of potential risks in their production and use, and the cost of not deploying this technology – the risk of continuing with the status quo alternative. Expand
Trends affecting the next generation of U.S. agricultural biotechnology: Politics, policy, and plant-made pharmaceuticals
Abstract This paper analyzes the structure and history of regulatory policies in the United States, focusing on recent regulatory changes due to the promise and threat posed by plant-madeExpand
Transgenic plants as factories for biopharmaceuticals
Transgenic plant-derived biopharmaceuticals, such as glucocerebrosidase, could become much cheaper and more plentiful through production in transgenic plants, making immunization programs in developing countries cheaper and potentially easier to administer. Expand
Plant-derived pharmaceuticals--the road forward.
Despite the promised benefits, the commercialization of plant-derived pharmaceutical products is overshadowed by the uncertain regulatory terrain, particularly with regard to the adaptation of good manufacturing practice regulations to field-grown plants. Expand
When crop transgenes wander in California, should we worry?
The best containment for transgenes may involve risk assessment decisions by scientists embarking on projects to determine whether the proposed combination of organism and trait will pose any problems and if so, to determine how to create a safe product. Expand
Plants and human health in the twenty-first century.
The history, future, scientific background and regulatory issues related to botanical therapeutics, including plant-derived pharmaceuticals, multicomponent botanical drugs, dietary supplements, functional foods and plant-produced recombinant proteins are discussed. Expand
Genetic modification: The production of recombinant pharmaceutical proteins in plants
Molecular farming in plants has already proven to be a successful way of producing a range of technical proteins and the first plant-derived recombinant pharmaceutical proteins are now approaching commercial approval, and many more are expected to follow. Expand